Medtronic, Inc. Release: Initial Data Presented on World’s First Pacemaker Designed for Safe Use in MRI Machines

MINNEAPOLIS & MUNICH, Germany--(BUSINESS WIRE)--Initial safety and efficacy data, presented today at the European Society of Cardiology Congress, on the Medtronic, Inc. (NYSE:MDT) investigational EnRhythm MRI™ SureScan™ Pacing System show promise for a potential solution for patients receiving their first pacemaker and needing an MRI scan.